Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Roche negotiates license to Ark's HIV drug monitoring assays

Executive Summary

Roche Diagnostics has signed a letter of intent to negotiate worldwide distribution and marketing rights to start-up Ark Diagnostics' immunoassays for HIV drug monitoring.
Deal Industry
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Therapeutic Drug Monitoring
Deal Status
  • Preliminary
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies